Steve Favaloro is currently the Chief Financial Officer of Arbor Biotech, a best-in-class biotechnology company discovering and developing the next generation of genetic medicines. He also advises several early-stage biotech companies, helping them to architect their financial and fundraising strategies.

Steve was formerly the Chief Financial Officer at Arranta Bio and Brammer Bio, with responsibility for overseeing the financial health and information systems during a period of rapid growth and the execution of a $200M capacity expansion program.

Steve received his BA in Economics from Boston College, and an MS in Finance and an MBA from the Carroll School of Management at Boston College.